Publications

Journal Article Ppublish 21 citations
Electronic publication date
May 18, 2021

View on Pubmed.gov 32006221 | View on doi.org 10.1007/s11739-...

Behçet's syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics.

Search for publications in this journal Intern Emerg Med - 15(6):1031-1039

Abstract

Behçet's syndrome (BS) is a multisystemic disorder displaying a marked variability across different geographic areas. The main aim of this study was to analyze demographic and clinical features of a cohort of BS patients diagnosed in three tertiary referral centers in Italy and detect potential associations between the different manifestations. Medical records of 396 patients (218 females, 178 males) were retrospectively analyzed. Mean age at onset was 30.00 ± 18.75 years with a female-to-male ratio of 1.22:1. Mucocutaneous features were the most frequent starting manifestations of BS, followed by eye inflammation. Erythema nodosum (p = 0.007), arthritis/arthralgias (p = 0.0115), and central nervous system (CNS) signs (p = 0.014) were significantly over-represented in female patients, whereas male gender was associated with lower mean age at onset (p = 0.031), higher frequency of pseudofollicular lesions, and uveitis (p = 0.00134 and p < 0.0001 respectively), particularly for posterior segment involvement and panuveitis (p < 0.0001). Regarding the association between disease features, genital ulcers were negatively associated with uveitis (p < 0.0001) and vascular involvement (p < 0.0001). Other negative associations were detected between uveitis and gastrointestinal involvement (p = 0.008), pseudofolliculitis and CNS signs (p = 0.031), vascular involvement (p = 0.002) and erythema nodosum (p = 0.013). Logistic regression identified male gender and genital ulcers, respectively, with a higher (OR 2.199 [1.397-3.461], p < 0.001) and lower risk (OR 0.157 [0.090-0.273], p < 0.0001) of developing major organ involvement. Our evaluations found that the disease had started mostly in the second and third decade with most severe features in the male gender, and that patients presenting with mucocutaneous manifestations were less prone to develop major organ involvement.

References

Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V (2018) One year in review 2018: Behçet's syndrome. Clin Exp Rheumatol 36(6 Suppl 115):13–27

Mat MC, Sevim A, Fresko I, Tüzün Y (2014) Behçet's disease as a systemic disease. Clin Dermatol 32:435–442

Emmi G, Prisco D (2019) Behçet's syndrome: focus on pathogenetic background, clinical phenotypes and specific treatments. Intern Emerg Med. 14:639–643

Emmi G, Bettiol A, Silvestri E, Di Scala G, Becatti M, Fiorillo C et al (2019) Vascular Behçet's syndrome: an update. Intern Emerg Med 14:645–652

Cited by 21 citations (total)

Journal Article

Clinical profile and evolution of patients with juvenile-onset Behçet's syndrome over a 25-year period: insights from the AIDA network.

Electronic publication date November 30, 2021

Search for publications in this journal Intern Emerg Med

Jurgen Sota [...] Luca Cantarini et al.

Behçet's syndrome (BS) represents an understudied topic in pediatrics: the main aims of our study were to characterize demographic and...

Journal Article

Tocilizumab in the treatment of severe and refractory parenchymal neuro-Behçet's syndrome: case series and literature review.

Electronic publication date November 27, 2020

Search for publications in this journal Ther Adv Musculoskelet Dis

Jinjing Liu [...] Wenjie Zheng et al.

OBJECTIVES

This study aimed to investigate the efficacy and safety of tocilizumab (TCZ) in severe and refractory parenchymal neuro-Behçet's syndrome (p-NBS).

METHODS

We...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties